<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - Drugs &amp; Healthcare</title>
<description>International Business News - Drugs &amp; Healthcare</description>
<link>http://ibtimes.co.uk/subsection/companies/drugshealth.htm</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://ibtimes.co.uk/</link> 
	<url>http://ibtimes.co.uk/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Alzheimer&amp;#039;s less likely for men over 90 than women</title>
  <description>Men are much less likely than women to live into their 90s, but those who do have a much lower chance of having Alzheimer&amp;#039;s disease or another form of dementia, U.S. researchers said on Wednesday.</description>
    <image>
  <url>http://ibtimes.co.uk/data/articleimgs/3736-hands.jpg</url>
  <link>http://ibtimes.co.uk/articles/20080730/alzheimer-039-disease-men-women-age.htm</link>
  </image>
    <link>http://ibtimes.co.uk/articles/20080730/alzheimer-039-disease-men-women-age.htm</link> 
  <pubDate>Wed, 30 Jul 2008 08:12:59 EDT</pubDate>
  </item>


  <item>
  <title>AstraZeneca bolstered by Seroquel patent victory</title>
  <description>AstraZeneca shares jumped more than 6 percent on Wednesday after the group won a key U.S. patent battle over its second-biggest selling drug, Seroquel, for schizophrenia and bipolar disorder.</description>
    <image>
  <url>http://ibtimes.co.uk/data/articleimgs/3726-david-brennan.jpg</url>
  <link>http://ibtimes.co.uk/articles/20080702/astrazeneca-seroquel-patent-battle.htm</link>
  </image>
    <link>http://ibtimes.co.uk/articles/20080702/astrazeneca-seroquel-patent-battle.htm</link> 
  <pubDate>Wed, 02 Jul 2008 12:56:59 EDT</pubDate>
  </item>


  <item>
  <title>Laser treatment could help kill superbugs: study</title>
  <description>A laser treatment that wipes out drug-resistant bacterial infections may one day help doctors tackle the growing problem of superbugs, British researchers said on Tuesday.</description>
    <image>
  <url>http://ibtimes.co.uk/data/articleimgs/3704-mrsa.jpg</url>
  <link>http://ibtimes.co.uk/articles/20080701/laser-treatment-kill-superbugs.htm</link>
  </image>
    <link>http://ibtimes.co.uk/articles/20080701/laser-treatment-kill-superbugs.htm</link> 
  <pubDate>Tue, 01 Jul 2008 07:58:59 EDT</pubDate>
  </item>


  <item>
  <title>Study links low IQ to vascular dementia risk</title>
  <description>A lower IQ increases a person&amp;#039;s risk of developing a common form of dementia, a study found on Wednesday.</description>
    <image>
  <url>http://ibtimes.co.uk/data/articleimgs/3643-boy.jpg</url>
  <link>http://ibtimes.co.uk/articles/20080626/low-vascular-dementia-risk.htm</link>
  </image>
    <link>http://ibtimes.co.uk/articles/20080626/low-vascular-dementia-risk.htm</link> 
  <pubDate>Thu, 26 Jun 2008 08:22:52 EDT</pubDate>
  </item>


  <item>
  <title>Controversial obesity drug gets final okay</title>
  <description>Sanofi-Aventis won a final green light for its obesity drug Acomplia from cost-effectiveness watchdog NICE on Wednesday, clearing the way for doctors to prescribe it on the state health service.</description>
    <link>http://ibtimes.co.uk/articles/20080625/obesity-drug-approved-acomplia.htm</link> 
  <pubDate>Wed, 25 Jun 2008 07:37:34 EDT</pubDate>
  </item>


  <item>
  <title>Vaccine doubles survival of deadly brain cancer</title>
  <description>A cancer vaccine more than doubled the survival time of people with the most common and deadly type of brain tumor, U.S. researchers said on Monday.</description>
    <image>
  <url>http://ibtimes.co.uk/data/articleimgs/3323-brain-scan.jpg</url>
  <link>http://ibtimes.co.uk/articles/20080603/vaccine-brain-cancer-survival.htm</link>
  </image>
    <link>http://ibtimes.co.uk/articles/20080603/vaccine-brain-cancer-survival.htm</link> 
  <pubDate>Tue, 03 Jun 2008 08:08:54 EDT</pubDate>
  </item>


  <item>
  <title>GlaxoSmithKline get EU approval for bird flu drug</title>
  <description>GlaxoSmithKline has been given approval by the European Union to sell a vaccine called Prepandrix, to counter the H5N1 strain of bird flu.</description>
    <link>http://ibtimes.co.uk/articles/20080519/glaxosmithkline-prepandrix-bird-flu-drug.htm</link> 
  <pubDate>Mon, 19 May 2008 08:38:05 EDT</pubDate>
  </item>


  <item>
  <title>Dennis Quaid backs drugmaker liability suits</title>
  <description>Actor Dennis Quaid urged the U.S. Congress on Wednesday to preserve patients&amp;#039; rights to sue drugmakers for injuries, recounting how his newborn twins nearly died from an accidental drug overdose.</description>
    <image>
  <url>http://ibtimes.co.uk/data/articleimgs/3167-dennis-quaid.jpg</url>
  <link>http://ibtimes.co.uk/articles/20080515/dennis-quaid-drugmaker-liability.htm</link>
  </image>
    <link>http://ibtimes.co.uk/articles/20080515/dennis-quaid-drugmaker-liability.htm</link> 
  <pubDate>Thu, 15 May 2008 21:57:10 EDT</pubDate>
  </item>


  <item>
  <title>Southern Cross revenue drops</title>
  <description>Southern Cross Healthcare Group Plc said on Monday that its total revenue for the half year to 30 March 2008 went up 28.2 per cent to £431.2 million. The company said that revenue relating to acquisitions had also risen from £9.0 million in the first half of 2007 to £20.1 million in the first half of 2008.</description>
    <link>http://ibtimes.co.uk/articles/20080512/southern-cross-revenue-first-half.htm</link> 
  <pubDate>Mon, 12 May 2008 22:34:58 EDT</pubDate>
  </item>


  <item>
  <title>United Drug profits up 15%</title>
  <description>United Drug Plc, on Tuesday said that its pre-tax profit for the six months ended 31 March 2008 went up 15 per cent to 33.28 million euros. The Irish drug-maker also reported a rise in revenue of 9 per cent to 845.07 million euros.</description>
    <link>http://ibtimes.co.uk/articles/20080506/united-drug-profit.htm</link> 
  <pubDate>Tue, 06 May 2008 08:35:14 EDT</pubDate>
  </item>


  <item>
  <title>Students take up HPV vaccine</title>
  <description>Up to 70 percent of British schoolgirls are likely to take up the offer of a vaccine to protect them against cervical cancer, despite doubts about other vaccines, researchers reported on Thursday.</description>
    <link>http://ibtimes.co.uk/articles/20080425/schoolgirls-hpv-vaccine-cervical-cancer.htm</link> 
  <pubDate>Fri, 25 Apr 2008 08:27:15 EDT</pubDate>
  </item>


  <item>
  <title>AstraZeneca Q4 profits fall</title>
  <description>Pharmaceutical giant AstraZeneca Plc has reported a rise in fourth quarter sales of 10 per cent to $7,677 million. The company&amp;#039;s pre-tax profit however was down 5.0 per cent to $2,143 million.</description>
    <image>
  <url>http://ibtimes.co.uk/data/articleimgs/2984-david-brennan.jpg</url>
  <link>http://ibtimes.co.uk/articles/20080424/astrazeneca-fourth-quarter-sales.htm</link>
  </image>
    <link>http://ibtimes.co.uk/articles/20080424/astrazeneca-fourth-quarter-sales.htm</link> 
  <pubDate>Thu, 24 Apr 2008 08:27:15 EDT</pubDate>
  </item>


  <item>
  <title>Healthcare Locums profits up 135%</title>
  <description>Healthcare Locums Plc has reported a 108 per cent growth in sales for the full year 2007, from £65 million to £135 million. The company said that its organic like-for-like profit growth rate was up to 21 per cent, a rise from the rate of 16 per cent in 2006.</description>
    <link>http://ibtimes.co.uk/articles/20080414/healthcare-locums-profits.htm</link> 
  <pubDate>Mon, 14 Apr 2008 08:33:11 EDT</pubDate>
  </item>


  <item>
  <title>CeNeS in takeover talks</title>
  <description>CeNeS Pharmaceuticals Plc saw its shares rise today after it announced discussions which could lead to a takeover of the company. At 1:25pm shares in the company had gone up 57.81 per cent.</description>
    <link>http://ibtimes.co.uk/articles/20080205/cenes-pharmaceuticals-takeover.htm</link> 
  <pubDate>Tue, 05 Feb 2008 13:47:34 EST</pubDate>
  </item>


  <item>
  <title>Glaxo and Synta drug gets orphan status from FDA</title>
  <description>Pharmaceutical company GlaxoSmithKline PLC and the American based Synta Pharmaceuticals have said that the US Food and Drug Administration (FDA) has granted the drug Elesclomol, orphan drug status. Elesclomol is a medicine meant to treat metastatic melanoma.</description>
    <link>http://ibtimes.co.uk/articles/20080128/glaxosmithkline-synta-elesclomol-food-and-drug-administration-pharmaceuticals.htm</link> 
  <pubDate>Mon, 28 Jan 2008 14:15:04 EST</pubDate>
  </item>


  <item>
  <title>Reckitt gets US permission to acquire Adams</title>
  <description>UK based Reckitt Benckiser Group have said that they have received antitrust approval from US regulators to acquire US drugmaker Adams Respiratory Therapeutics.</description>
    <link>http://ibtimes.co.uk/articles/20080108/reckitt-benckiser-group-adams-respiratory-therapeutics-takeover.htm</link> 
  <pubDate>Tue, 08 Jan 2008 07:54:18 EST</pubDate>
  </item>


  <item>
  <title>Broker says Astra&amp;#039;s Crestor may face patent threat</title>
  <description>Five generic firms have recently filed manufacturing applications with the U.S. Food and Drug Administration to make a form of AstraZeneca&amp;#039;s cholesterol drug Crestor, suggesting a patent challenge could be imminent, according to Citigroup analysts.</description>
    <image>
  <url>http://ibtimes.co.uk/data/articleimgs/1846.jpg</url>
  <link>http://ibtimes.co.uk/articles/20070831/astrazeneca-cholesterol-drug-crestor-manufacturing-applications.htm</link>
  </image>
    <link>http://ibtimes.co.uk/articles/20070831/astrazeneca-cholesterol-drug-crestor-manufacturing-applications.htm</link> 
  <pubDate>Fri, 31 Aug 2007 03:57:09 EDT</pubDate>
  </item>


  <item>
  <title>Smiths sees flat headline operating profit</title>
  <description>Specialty engineering, detection and medical equipment maker Smiths Group said on Wednesday it expected a weak dollar to keep headline operating profit for the year ended July 31 level with the preceeding year.</description>
    <image>
  <url>http://ibtimes.co.uk/data/articleimgs/1794.jpg</url>
  <link>http://ibtimes.co.uk/articles/20070808/smiths-group-operating-profit.htm</link>
  </image>
    <link>http://ibtimes.co.uk/articles/20070808/smiths-group-operating-profit.htm</link> 
  <pubDate>Wed, 08 Aug 2007 04:23:04 EDT</pubDate>
  </item>


  <item>
  <title>New study slams Avandia safety</title>
  <description>The safety of GlaxoSmithKline&amp;#039;s controversial diabetes drug Avandia was attacked in a new analysis by German researchers on Wednesday, dealing a fresh blow to the group&amp;#039;s second biggest product.</description>
    <image>
  <url>http://ibtimes.co.uk/data/articleimgs/1747.jpg</url>
  <link>http://ibtimes.co.uk/articles/20070718/glaxosmithkline-diabetes-drub-avandia-attacked.htm</link>
  </image>
    <link>http://ibtimes.co.uk/articles/20070718/glaxosmithkline-diabetes-drub-avandia-attacked.htm</link> 
  <pubDate>Wed, 18 Jul 2007 03:10:03 EDT</pubDate>
  </item>


  <item>
  <title>Glaxo drug cuts bleeding in study</title>
  <description>GlaxoSmithKline&amp;#039;s experimental platelet boosting drug eltrombopag has produced further positive results in patients with idiopathic thrombocytopenia purpura (ITP), researchers said on Saturday.</description>
    <image>
  <url>http://ibtimes.co.uk/data/articleimgs/1697.jpg</url>
  <link>http://ibtimes.co.uk/articles/20070609/glaxosmithkline-experimental-drug-reduces-bleeding-study.htm</link>
  </image>
    <link>http://ibtimes.co.uk/articles/20070609/glaxosmithkline-experimental-drug-reduces-bleeding-study.htm</link> 
  <pubDate>Sat, 09 Jun 2007 06:33:26 EDT</pubDate>
  </item>


</channel>
</rss>